Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells-Reference-Cited by-同舟云学术

Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells

Published:2022-06-09 Issue:11 Volume:29 Page:1676-1685
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Zaffran Ilan,Landolina Nadine^ORCID,Gaur Pratibha,Rovis Tihana Lenac,Jonjic Stipan,Mandelboim Ofer,Singer Bernhard B.^ORCID,Levi-Schaffer Francesca^ORCID

Funder

Israel Cancer Association

Aimwell Charitable Trust (UK), by INTEGRA holdings

Israeli Scholarship Education Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

https://www.nature.com/articles/s41417-022-00486-x.pdf

Reference43 articles.

1. Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020;11:3801.

2. Markel G, Sapir Y, Mandel I, Hakim M, Shaked R, Meilin E, et al. Inhibition of the novel immune checkpoint CEACAM1 to enhance anti-tumor immunological activity. J Clin Oncol. 2016;34:3044.

3. Helfrich I, Singer BB. Size matters: the functional role of the CEACAM1 isoform signature and its impact for NK cell-mediated killing in melanoma. Cancers. 2019;11:356.

4. Singer BB, Scheffrahn I, Heymann R, Sigmundsson K, Kammerer R, Öbrink B. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. J Immunol. 2002;168:5139–46.

5. Öbrink B. On the role of CEACAM1 in cancer. Lung Cancer. 2008;60:309–12.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer;Frontiers in Immunology;2023-11-24

2. Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells;Cancer Gene Therapy;2023-02-03